Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients
暂无分享,去创建一个
E. Maccaroni | L. Belvederesi | S. Cascinu | C. Loretelli | E. Galizia | M. Scartozzi | M. Del Prete | A. Bittoni | R. Giampieri | L. Faloppi | M. Bianconi | M. Prete